| 
																	
																	
																		 Aline Andres
 
																		 Concepts  (347)
																		
																	 
																		Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months. 
																			
																					
    Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
     | Name | Number of Publications | Most Recent Publication | Publications by All Authors | Concept Score | Why? | 
|---|
 | Milk, Human | 20 | 2025 | 105 | 5.490 | Why? |  | Body Composition | 17 | 2024 | 338 | 4.530 | Why? |  | Adiposity | 11 | 2024 | 143 | 4.420 | Why? |  | Body Mass Index | 23 | 2024 | 689 | 4.010 | Why? |  | Breast Feeding | 25 | 2024 | 197 | 3.980 | Why? |  | Obesity | 29 | 2025 | 1162 | 3.900 | Why? |  | Pregnancy | 49 | 2025 | 2680 | 3.530 | Why? |  | Weight Gain | 14 | 2025 | 240 | 3.000 | Why? |  | Overweight | 11 | 2024 | 224 | 2.590 | Why? |  | Infant Formula | 20 | 2025 | 147 | 2.450 | Why? |  | Exercise | 10 | 2024 | 547 | 2.440 | Why? |  | Mothers | 8 | 2024 | 270 | 2.380 | Why? |  | Adipose Tissue | 8 | 2025 | 204 | 2.360 | Why? |  | Child Development | 11 | 2025 | 200 | 2.320 | Why? |  | Maternal Exposure | 4 | 2025 | 103 | 2.120 | Why? |  | Female | 87 | 2025 | 28171 | 2.010 | Why? |  | Fluorocarbons | 3 | 2025 | 61 | 2.010 | Why? |  | Infant | 41 | 2025 | 3733 | 1.980 | Why? |  | Longitudinal Studies | 20 | 2025 | 747 | 1.910 | Why? |  | Environmental Pollutants | 3 | 2025 | 106 | 1.910 | Why? |  | Maternal Nutritional Physiological Phenomena | 6 | 2021 | 58 | 1.900 | Why? |  | Pregnancy Complications | 11 | 2024 | 400 | 1.740 | Why? |  | Oligosaccharides | 5 | 2024 | 34 | 1.660 | Why? |  | Breast Milk Expression | 2 | 2023 | 4 | 1.650 | Why? |  | Milk | 9 | 2023 | 81 | 1.640 | Why? |  | Humans | 95 | 2025 | 52483 | 1.490 | Why? |  | Absorptiometry, Photon | 7 | 2023 | 162 | 1.470 | Why? |  | Insulin Resistance | 8 | 2021 | 275 | 1.420 | Why? |  | Diet | 15 | 2025 | 587 | 1.370 | Why? |  | Plethysmography | 5 | 2020 | 43 | 1.350 | Why? |  | Placenta | 5 | 2025 | 153 | 1.340 | Why? |  | Child, Preschool | 19 | 2025 | 4076 | 1.290 | Why? |  | Follicular Fluid | 2 | 2019 | 9 | 1.170 | Why? |  | Pregnant Women | 5 | 2022 | 70 | 1.160 | Why? |  | Infant, Newborn | 25 | 2025 | 2867 | 1.150 | Why? |  | Cohort Studies | 14 | 2024 | 1542 | 1.130 | Why? |  | Infant Nutritional Physiological Phenomena | 7 | 2023 | 54 | 1.130 | Why? |  | Adult | 33 | 2025 | 14161 | 1.120 | Why? |  | Infant Food | 3 | 2020 | 28 | 1.120 | Why? |  | Bottle Feeding | 5 | 2020 | 34 | 1.110 | Why? |  | Postpartum Period | 4 | 2023 | 109 | 1.010 | Why? |  | DNA Methylation | 5 | 2025 | 592 | 0.990 | Why? |  | Isoleucine | 2 | 2024 | 26 | 0.980 | Why? |  | Anthropometry | 6 | 2024 | 101 | 0.940 | Why? |  | Male | 42 | 2025 | 26761 | 0.930 | Why? |  | Magnetic Resonance Spectroscopy | 2 | 2020 | 253 | 0.930 | Why? |  | Metabolome | 3 | 2020 | 101 | 0.900 | Why? |  | Child | 17 | 2024 | 7248 | 0.860 | Why? |  | Lipid Metabolism | 4 | 2019 | 187 | 0.820 | Why? |  | Growth | 3 | 2020 | 40 | 0.810 | Why? |  | Eating | 2 | 2021 | 159 | 0.800 | Why? |  | Prenatal Care | 3 | 2023 | 110 | 0.790 | Why? |  | Blood Glucose | 3 | 2020 | 473 | 0.790 | Why? |  | Sleep | 1 | 2023 | 187 | 0.760 | Why? |  | Pregnancy Trimester, First | 2 | 2023 | 23 | 0.740 | Why? |  | Homeostasis | 2 | 2020 | 201 | 0.730 | Why? |  | Monosaccharides | 1 | 2020 | 7 | 0.710 | Why? |  | Leptin | 3 | 2022 | 148 | 0.700 | Why? |  | Gestational Age | 6 | 2025 | 417 | 0.680 | Why? |  | Pregnancy Trimester, Third | 1 | 2020 | 57 | 0.680 | Why? |  | Dietary Proteins | 2 | 2020 | 252 | 0.680 | Why? |  | Parents | 2 | 2022 | 335 | 0.670 | Why? |  | Maternal-Fetal Exchange | 1 | 2020 | 49 | 0.670 | Why? |  | Isoflavones | 4 | 2009 | 88 | 0.660 | Why? |  | Early Growth Response Protein 1 | 3 | 2016 | 34 | 0.640 | Why? |  | Body Weight | 3 | 2021 | 523 | 0.640 | Why? |  | Fertilization in Vitro | 1 | 2019 | 31 | 0.620 | Why? |  | Young Adult | 10 | 2025 | 4329 | 0.590 | Why? |  | Lactation | 4 | 2023 | 60 | 0.590 | Why? |  | Soy Milk | 6 | 2018 | 37 | 0.580 | Why? |  | Arkansas | 7 | 2025 | 2028 | 0.560 | Why? |  | Directive Counseling | 1 | 2017 | 23 | 0.530 | Why? |  | Antioxidants | 1 | 2019 | 256 | 0.530 | Why? |  | Oocytes | 1 | 2017 | 92 | 0.520 | Why? |  | Ovary | 2 | 2016 | 107 | 0.520 | Why? |  | C-Reactive Protein | 1 | 2017 | 155 | 0.510 | Why? |  | Triglycerides | 1 | 2017 | 165 | 0.510 | Why? |  | Prenatal Diagnosis | 1 | 2016 | 103 | 0.500 | Why? |  | Body Water | 2 | 2012 | 27 | 0.480 | Why? |  | Patient Compliance | 1 | 2017 | 230 | 0.480 | Why? |  | Sexual Development | 1 | 2015 | 6 | 0.480 | Why? |  | Behavior Therapy | 1 | 2017 | 179 | 0.480 | Why? |  | Genitalia, Male | 1 | 2015 | 14 | 0.480 | Why? |  | Soybean Proteins | 4 | 2020 | 162 | 0.470 | Why? |  | Soy Foods | 1 | 2015 | 20 | 0.470 | Why? |  | Genitalia, Female | 1 | 2015 | 19 | 0.470 | Why? |  | Child of Impaired Parents | 1 | 2015 | 42 | 0.470 | Why? |  | Risk Factors | 6 | 2024 | 3889 | 0.450 | Why? |  | Animals | 19 | 2025 | 13505 | 0.440 | Why? |  | Oxidative Stress | 1 | 2019 | 807 | 0.440 | Why? |  | Feces | 3 | 2024 | 153 | 0.410 | Why? |  | Diet, High-Fat | 4 | 2025 | 236 | 0.400 | Why? |  | Infant Behavior | 1 | 2012 | 18 | 0.390 | Why? |  | Bone Density | 2 | 2023 | 399 | 0.390 | Why? |  | Epigenesis, Genetic | 2 | 2025 | 406 | 0.370 | Why? |  | Case-Control Studies | 4 | 2019 | 1201 | 0.360 | Why? |  | RNA, Ribosomal, 16S | 4 | 2024 | 118 | 0.360 | Why? |  | Military Personnel | 2 | 2023 | 177 | 0.350 | Why? |  | Umbilical Cord | 3 | 2017 | 36 | 0.350 | Why? |  | Insulin | 4 | 2022 | 479 | 0.340 | Why? |  | Cross-Sectional Studies | 3 | 2024 | 1678 | 0.340 | Why? |  | Feeding Behavior | 2 | 2024 | 192 | 0.340 | Why? |  | Food Supply | 2 | 2023 | 92 | 0.330 | Why? |  | Phenotype | 3 | 2023 | 789 | 0.330 | Why? |  | Linear Models | 2 | 2021 | 287 | 0.330 | Why? |  | Birth Weight | 4 | 2025 | 125 | 0.320 | Why? |  | Magnetic Resonance Imaging | 3 | 2020 | 1546 | 0.320 | Why? |  | Viruses | 1 | 2009 | 25 | 0.310 | Why? |  | Virus Diseases | 1 | 2009 | 46 | 0.300 | Why? |  | Rotavirus | 2 | 2009 | 9 | 0.300 | Why? |  | Brain | 7 | 2025 | 1323 | 0.300 | Why? |  | Electroencephalography | 4 | 2025 | 312 | 0.300 | Why? |  | Antiviral Agents | 1 | 2009 | 178 | 0.290 | Why? |  | Speech Perception | 3 | 2016 | 98 | 0.280 | Why? |  | Inflammation | 3 | 2017 | 641 | 0.270 | Why? |  | Breast | 2 | 2023 | 85 | 0.270 | Why? |  | Interleukin-8 | 2 | 2024 | 86 | 0.240 | Why? |  | Pregnancy Trimesters | 1 | 2025 | 13 | 0.240 | Why? |  | Alkanesulfonic Acids | 1 | 2025 | 10 | 0.240 | Why? |  | Placentation | 1 | 2025 | 13 | 0.230 | Why? |  | Diffusion Tensor Imaging | 3 | 2023 | 95 | 0.230 | Why? |  | Heart | 2 | 2020 | 345 | 0.230 | Why? |  | Heat-Shock Proteins | 1 | 2025 | 103 | 0.230 | Why? |  | Temperament | 1 | 2024 | 23 | 0.230 | Why? |  | Fathers | 1 | 2024 | 26 | 0.230 | Why? |  | Vagus Nerve | 2 | 2015 | 23 | 0.220 | Why? |  | Evoked Potentials | 2 | 2016 | 67 | 0.220 | Why? |  | Fast Foods | 1 | 2023 | 9 | 0.210 | Why? |  | Prospective Studies | 5 | 2023 | 2481 | 0.210 | Why? |  | Sodium, Dietary | 1 | 2023 | 24 | 0.210 | Why? |  | Amino Acids, Branched-Chain | 2 | 2021 | 43 | 0.210 | Why? |  | Prenatal Exposure Delayed Effects | 1 | 2025 | 197 | 0.200 | Why? |  | Immunity, Innate | 1 | 2024 | 117 | 0.200 | Why? |  | Matrix Attachment Region Binding Proteins | 1 | 2023 | 37 | 0.200 | Why? |  | Sex Factors | 5 | 2025 | 727 | 0.200 | Why? |  | Intention | 1 | 2023 | 48 | 0.200 | Why? |  | Bone Diseases, Metabolic | 1 | 2023 | 78 | 0.200 | Why? |  | Hypersensitivity | 1 | 2023 | 81 | 0.200 | Why? |  | Accelerometry | 1 | 2022 | 14 | 0.200 | Why? |  | Metabolomics | 2 | 2020 | 150 | 0.200 | Why? |  | Follow-Up Studies | 3 | 2019 | 2279 | 0.190 | Why? |  | Educational Status | 1 | 2023 | 226 | 0.190 | Why? |  | Immunoglobulin A | 1 | 2021 | 45 | 0.190 | Why? |  | Lipids | 1 | 2022 | 155 | 0.190 | Why? |  | Depressive Disorder, Major | 1 | 2023 | 148 | 0.190 | Why? |  | Metabolic Networks and Pathways | 2 | 2019 | 93 | 0.190 | Why? |  | Antibodies, Viral | 1 | 2021 | 109 | 0.180 | Why? |  | Leucine | 1 | 2021 | 114 | 0.180 | Why? |  | Predictive Value of Tests | 2 | 2016 | 944 | 0.180 | Why? |  | Urinalysis | 1 | 2020 | 33 | 0.170 | Why? |  | Cattle | 3 | 2020 | 205 | 0.170 | Why? |  | Body Fat Distribution | 1 | 2020 | 10 | 0.170 | Why? |  | Models, Biological | 2 | 2020 | 735 | 0.170 | Why? |  | Body Weights and Measures | 1 | 2020 | 17 | 0.170 | Why? |  | Adolescent | 3 | 2019 | 6739 | 0.170 | Why? |  | Health Status | 2 | 2020 | 294 | 0.170 | Why? |  | Physical Conditioning, Animal | 1 | 2020 | 59 | 0.160 | Why? |  | Health Behavior | 1 | 2022 | 257 | 0.160 | Why? |  | Exercise Therapy | 1 | 2020 | 100 | 0.160 | Why? |  | Transcriptome | 3 | 2018 | 370 | 0.160 | Why? |  | Insulin-Like Growth Factor I | 1 | 2019 | 139 | 0.160 | Why? |  | Chromatography, High Pressure Liquid | 1 | 2020 | 339 | 0.160 | Why? |  | Uric Acid | 1 | 2019 | 25 | 0.150 | Why? |  | Diabetes, Gestational | 1 | 2019 | 53 | 0.150 | Why? |  | GABAergic Neurons | 1 | 2018 | 10 | 0.150 | Why? |  | Cardiovascular Diseases | 1 | 2024 | 490 | 0.150 | Why? |  | Feasibility Studies | 1 | 2020 | 406 | 0.150 | Why? |  | Purines | 1 | 2018 | 34 | 0.150 | Why? |  | Real-Time Polymerase Chain Reaction | 2 | 2016 | 185 | 0.150 | Why? |  | Pilot Projects | 1 | 2020 | 721 | 0.140 | Why? |  | Adipogenesis | 2 | 2016 | 49 | 0.140 | Why? |  | Exosomes | 1 | 2018 | 58 | 0.140 | Why? |  | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2016 | 582 | 0.140 | Why? |  | Oocyte Retrieval | 1 | 2017 | 5 | 0.140 | Why? |  | Chemokine CXCL2 | 1 | 2017 | 11 | 0.140 | Why? |  | Ovulation Induction | 1 | 2017 | 11 | 0.140 | Why? |  | Inhibitor of Differentiation Proteins | 1 | 2017 | 6 | 0.140 | Why? |  | Dual Specificity Phosphatase 1 | 1 | 2017 | 10 | 0.140 | Why? |  | Randomized Controlled Trials as Topic | 1 | 2020 | 595 | 0.140 | Why? |  | Fatty Liver | 1 | 2018 | 142 | 0.140 | Why? |  | Parity | 1 | 2017 | 52 | 0.140 | Why? |  | Ideal Body Weight | 1 | 2017 | 6 | 0.140 | Why? |  | Friends | 1 | 2017 | 19 | 0.130 | Why? |  | Tumor Necrosis Factor-alpha | 2 | 2016 | 399 | 0.130 | Why? |  | Gene Expression Profiling | 3 | 2017 | 1105 | 0.130 | Why? |  | Organ Size | 2 | 2015 | 228 | 0.130 | Why? |  | Mice, Inbred C57BL | 4 | 2025 | 1884 | 0.130 | Why? |  | Sequence Analysis, RNA | 1 | 2017 | 100 | 0.130 | Why? |  | Single-Cell Analysis | 1 | 2017 | 81 | 0.130 | Why? |  | Receptors, Interleukin-8A | 1 | 2016 | 6 | 0.130 | Why? |  | Chemokine CXCL11 | 1 | 2016 | 7 | 0.130 | Why? |  | Granulosa Cells | 1 | 2016 | 12 | 0.130 | Why? |  | Versicans | 1 | 2016 | 10 | 0.130 | Why? |  | Glucose Transporter Type 4 | 1 | 2016 | 23 | 0.130 | Why? |  | Sex Characteristics | 2 | 2018 | 198 | 0.130 | Why? |  | Chemokine CXCL10 | 1 | 2016 | 20 | 0.130 | Why? |  | Monosaccharide Transport Proteins | 1 | 2016 | 14 | 0.130 | Why? |  | Tissue Array Analysis | 1 | 2016 | 46 | 0.130 | Why? |  | Receptors, CCR2 | 1 | 2016 | 13 | 0.130 | Why? |  | Amino Acids | 1 | 2019 | 377 | 0.130 | Why? |  | Food, Formulated | 2 | 2023 | 42 | 0.130 | Why? |  | Guidelines as Topic | 1 | 2017 | 111 | 0.130 | Why? |  | Immunoblotting | 1 | 2016 | 116 | 0.130 | Why? |  | Chemokine CCL2 | 1 | 2016 | 69 | 0.130 | Why? |  | Rats, Sprague-Dawley | 2 | 2016 | 1563 | 0.120 | Why? |  | Phosphoproteins | 1 | 2016 | 119 | 0.120 | Why? |  | Nerve Tissue Proteins | 1 | 2017 | 187 | 0.120 | Why? |  | Family | 1 | 2017 | 176 | 0.120 | Why? |  | Proto-Oncogene Proteins c-akt | 1 | 2016 | 169 | 0.120 | Why? |  | RNA, Messenger | 2 | 2016 | 1132 | 0.120 | Why? |  | Carrier Proteins | 1 | 2017 | 313 | 0.120 | Why? |  | Cerebral Cortex | 1 | 2016 | 198 | 0.120 | Why? |  | Phosphatidylinositol 3-Kinases | 1 | 2016 | 151 | 0.120 | Why? |  | Tissue Plasminogen Activator | 1 | 2016 | 109 | 0.120 | Why? |  | Ultrasonography | 2 | 2015 | 430 | 0.120 | Why? |  | Premature Birth | 1 | 2017 | 153 | 0.120 | Why? |  | Neoplasm Proteins | 1 | 2017 | 334 | 0.120 | Why? |  | MicroRNAs | 1 | 2018 | 387 | 0.110 | Why? |  | Up-Regulation | 1 | 2016 | 454 | 0.110 | Why? |  | Autonomic Nervous System | 1 | 2015 | 60 | 0.110 | Why? |  | Mice | 5 | 2025 | 5949 | 0.110 | Why? |  | Diabetes Mellitus, Type 2 | 1 | 2020 | 560 | 0.110 | Why? |  | Gene Expression Regulation | 2 | 2020 | 990 | 0.110 | Why? |  | Time Factors | 1 | 2020 | 2968 | 0.110 | Why? |  | Prognosis | 1 | 2019 | 2099 | 0.110 | Why? |  | Immunohistochemistry | 1 | 2016 | 979 | 0.100 | Why? |  | Deuterium Oxide | 1 | 2012 | 10 | 0.100 | Why? |  | Air | 1 | 2012 | 23 | 0.100 | Why? |  | Liver | 1 | 2018 | 1156 | 0.100 | Why? |  | Health Knowledge, Attitudes, Practice | 1 | 2017 | 509 | 0.100 | Why? |  | Life Style | 2 | 2023 | 145 | 0.100 | Why? |  | Bacteria | 3 | 2022 | 228 | 0.100 | Why? |  | Disease Susceptibility | 1 | 2012 | 95 | 0.100 | Why? |  | Swine | 2 | 2010 | 428 | 0.090 | Why? |  | Cell Differentiation | 1 | 2014 | 665 | 0.090 | Why? |  | Evoked Potentials, Auditory | 1 | 2011 | 90 | 0.090 | Why? |  | Sensitivity and Specificity | 1 | 2012 | 891 | 0.080 | Why? |  | Calibration | 1 | 2010 | 57 | 0.080 | Why? |  | Genitalia | 1 | 2009 | 10 | 0.080 | Why? |  | Radionuclide Imaging | 1 | 2010 | 107 | 0.080 | Why? |  | United States | 2 | 2020 | 5192 | 0.080 | Why? |  | Anticarcinogenic Agents | 1 | 2009 | 32 | 0.080 | Why? |  | Phytoestrogens | 1 | 2009 | 23 | 0.080 | Why? |  | Genistein | 1 | 2009 | 45 | 0.080 | Why? |  | Biological Availability | 1 | 2009 | 108 | 0.080 | Why? |  | Flavonoids | 1 | 2009 | 54 | 0.080 | Why? |  | Cell Line | 2 | 2013 | 1030 | 0.080 | Why? |  | Species Specificity | 1 | 2009 | 192 | 0.080 | Why? |  | Reproducibility of Results | 1 | 2012 | 1229 | 0.080 | Why? |  | Gastrointestinal Tract | 1 | 2009 | 108 | 0.080 | Why? |  | Palmitates | 2 | 2022 | 29 | 0.080 | Why? |  | Gastrointestinal Diseases | 1 | 2009 | 125 | 0.070 | Why? |  | Rifabutin | 1 | 2007 | 5 | 0.070 | Why? |  | Lactams, Macrocyclic | 1 | 2007 | 15 | 0.070 | Why? |  | Benzoquinones | 1 | 2007 | 33 | 0.070 | Why? |  | Microscopy, Electron, Transmission | 1 | 2007 | 78 | 0.070 | Why? |  | Etoposide | 1 | 2007 | 74 | 0.070 | Why? |  | Analysis of Variance | 3 | 2014 | 554 | 0.070 | Why? |  | Estradiol | 1 | 2007 | 214 | 0.060 | Why? |  | Regression Analysis | 2 | 2017 | 401 | 0.060 | Why? |  | Body Height | 1 | 2025 | 66 | 0.060 | Why? |  | Bifidobacterium | 1 | 2024 | 5 | 0.060 | Why? |  | Mother-Child Relations | 1 | 2024 | 55 | 0.060 | Why? |  | Language Development | 2 | 2016 | 26 | 0.050 | Why? |  | Disease Models, Animal | 1 | 2009 | 1478 | 0.050 | Why? |  | Leukocytes, Mononuclear | 1 | 2024 | 123 | 0.050 | Why? |  | Immune System | 1 | 2024 | 42 | 0.050 | Why? |  | Food Handling | 1 | 2023 | 14 | 0.050 | Why? |  | Vitamins | 1 | 2023 | 64 | 0.050 | Why? |  | Alkaline Phosphatase | 1 | 2023 | 94 | 0.050 | Why? |  | Lymphocytes | 1 | 2024 | 153 | 0.050 | Why? |  | Osteocalcin | 1 | 2023 | 45 | 0.050 | Why? |  | Nutritional Status | 1 | 2023 | 137 | 0.050 | Why? |  | Syndrome | 1 | 2023 | 247 | 0.050 | Why? |  | Energy Intake | 1 | 2023 | 174 | 0.050 | Why? |  | Nutrition Surveys | 1 | 2023 | 117 | 0.050 | Why? |  | Stress, Psychological | 1 | 2024 | 273 | 0.050 | Why? |  | Butyrates | 1 | 2022 | 30 | 0.050 | Why? |  | Gene Expression | 1 | 2024 | 618 | 0.050 | Why? |  | Immunization, Passive | 1 | 2021 | 29 | 0.050 | Why? |  | Carnitine | 1 | 2022 | 68 | 0.050 | Why? |  | Weight Loss | 1 | 2023 | 248 | 0.050 | Why? |  | Self Report | 1 | 2022 | 210 | 0.050 | Why? |  | RNA, Viral | 1 | 2021 | 127 | 0.050 | Why? |  | Phonetics | 2 | 2011 | 43 | 0.040 | Why? |  | Health Promotion | 1 | 2023 | 270 | 0.040 | Why? |  | Age Factors | 2 | 2014 | 1132 | 0.040 | Why? |  | Electric Impedance | 1 | 2020 | 49 | 0.040 | Why? |  | Optical Imaging | 1 | 2020 | 26 | 0.040 | Why? |  | National Institutes of Health (U.S.) | 1 | 2020 | 43 | 0.040 | Why? |  | Transcription Factors | 1 | 2023 | 566 | 0.040 | Why? |  | CpG Islands | 1 | 2020 | 121 | 0.040 | Why? |  | Mental Disorders | 1 | 2024 | 428 | 0.040 | Why? |  | Bone and Bones | 1 | 2023 | 494 | 0.040 | Why? |  | Language | 1 | 2020 | 138 | 0.040 | Why? |  | Energy Metabolism | 1 | 2022 | 302 | 0.040 | Why? |  | Metagenome | 1 | 2018 | 40 | 0.040 | Why? |  | Biodiversity | 1 | 2018 | 52 | 0.040 | Why? |  | Metagenomics | 1 | 2018 | 46 | 0.040 | Why? |  | Community-Based Participatory Research | 1 | 2020 | 203 | 0.040 | Why? |  | Bile Acids and Salts | 1 | 2018 | 80 | 0.040 | Why? |  | Depression | 1 | 2023 | 600 | 0.040 | Why? |  | RNA | 1 | 2018 | 168 | 0.040 | Why? |  | Phylogeny | 1 | 2018 | 231 | 0.040 | Why? |  | Myocardium | 1 | 2020 | 453 | 0.030 | Why? |  | AMP-Activated Protein Kinases | 1 | 2017 | 31 | 0.030 | Why? |  | Mice, Knockout | 1 | 2020 | 879 | 0.030 | Why? |  | Insulin-Like Growth Factor Binding Protein 1 | 1 | 2017 | 17 | 0.030 | Why? |  | Thinness | 1 | 2016 | 44 | 0.030 | Why? |  | Skull | 1 | 2016 | 80 | 0.030 | Why? |  | Thiazolidinediones | 1 | 2016 | 83 | 0.030 | Why? |  | Anisotropy | 1 | 2015 | 61 | 0.030 | Why? |  | Child Language | 1 | 2014 | 10 | 0.030 | Why? |  | Intelligence Tests | 1 | 2014 | 39 | 0.030 | Why? |  | Proteins | 1 | 2017 | 348 | 0.030 | Why? |  | Intelligence | 1 | 2014 | 52 | 0.030 | Why? |  | Glucose | 1 | 2016 | 355 | 0.030 | Why? |  | Proto-Oncogene Proteins c-fos | 1 | 2014 | 60 | 0.030 | Why? |  | Microarray Analysis | 1 | 2014 | 71 | 0.030 | Why? |  | Culture Media | 1 | 2014 | 98 | 0.030 | Why? |  | DNA Primers | 1 | 2014 | 208 | 0.030 | Why? |  | Cell Adhesion Molecules | 1 | 2014 | 86 | 0.030 | Why? |  | Osteogenesis | 1 | 2016 | 366 | 0.030 | Why? |  | Human Umbilical Vein Endothelial Cells | 1 | 2014 | 99 | 0.030 | Why? |  | Diffusion Magnetic Resonance Imaging | 1 | 2014 | 133 | 0.030 | Why? |  | Activating Transcription Factor 3 | 1 | 2013 | 8 | 0.030 | Why? |  | Trophoblasts | 1 | 2013 | 31 | 0.030 | Why? |  | Neuropsychological Tests | 1 | 2014 | 338 | 0.030 | Why? |  | Cells, Cultured | 1 | 2016 | 1567 | 0.030 | Why? |  | Blotting, Western | 1 | 2014 | 590 | 0.030 | Why? |  | Serum Response Factor | 1 | 2013 | 43 | 0.030 | Why? |  | Genotype | 1 | 2014 | 566 | 0.030 | Why? |  | MAP Kinase Signaling System | 1 | 2013 | 121 | 0.020 | Why? |  | Cell Proliferation | 1 | 2016 | 1023 | 0.020 | Why? |  | Interleukin-6 | 1 | 2013 | 278 | 0.020 | Why? |  | Milk Substitutes | 1 | 2010 | 5 | 0.020 | Why? |  | Speech Acoustics | 1 | 2010 | 19 | 0.020 | Why? |  | Rats | 1 | 2016 | 3220 | 0.020 | Why? |  | Diarrhea, Infantile | 1 | 2009 | 5 | 0.020 | Why? |  | Rotavirus Infections | 1 | 2009 | 6 | 0.020 | Why? |  | Single-Blind Method | 1 | 2009 | 116 | 0.020 | Why? |  | Signal Transduction | 1 | 2016 | 1671 | 0.020 | Why? |  | Testis | 1 | 2009 | 72 | 0.020 | Why? |  | Uterus | 1 | 2009 | 88 | 0.020 | Why? |  | Prostate | 1 | 2009 | 116 | 0.020 | Why? |  | Bone Development | 1 | 2009 | 66 | 0.020 | Why? |  | Animals, Newborn | 1 | 2009 | 362 | 0.020 | Why? | 
 | 
																	
																		
																			
																					
    Andres's Networks
 
Click the "See All" links for more information and interactive visualizations!
 Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH._ Co-Authors  People in Profiles who have published with this person._ Similar People  People who share similar concepts with this person._ 
            
                Same Department   
				People who are also in this person's primary department.
			 |